Cai T - Search Results

1

Loss of heterozygosis on IFN-alpha locus is a prognostic indicator of bacillus Calmette-Guerin response for nonmuscle invasive bladder cancer.

Cai T, Nesi G, Dal Canto M, Tinacci G, Mondaini N, Piazzini M, Geppetti P, Bartoletti R. Cai T, et al. J Urol. 2010 May;183(5):1738-43. doi: 10.1016/j.juro.2009.12.105. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299058

2

Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.

Bartoletti R, Dal Canto M, Cai T, Piazzini M, Travaglini F, Gavazzi A, Rizzo M. Bartoletti R, et al. Among authors: cai t. Oncol Rep. 2005 Mar;13(3):531-7. Oncol Rep. 2005. PMID: 15706429 Clinical Trial.

3

Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.

Bartoletti R, Cai T, Nesi G, Sardi I, Rizzo M. Bartoletti R, et al. Among authors: cai t. Oncol Rep. 2005 Jul;14(1):251-5. Oncol Rep. 2005. PMID: 15944797

4

Quality of life after radical treatment of prostate cancer: validation of the Italian version of the University of California-Los Angeles Prostate Cancer Index.

Gacci M, Livi L, Paiar F, Detti B, Litwin MS, Bartoletti R, Giubilei G, Cai T, Mariani M, Carini M. Gacci M, et al. Among authors: cai t. Urology. 2005 Aug;66(2):338-43. doi: 10.1016/j.urology.2005.02.027. Urology. 2005. PMID: 16098363

5

Giant stone in enterocystoplasty.

Gacci M, Cai T, Travaglini F, Rizzo M, Bartoletti R, Carini M. Gacci M, et al. Among authors: cai t. Urol Int. 2005;75(2):181-3. doi: 10.1159/000087175. Urol Int. 2005. PMID: 16123575 Review.

6

Intravesical gemcitabine therapy for superficial transitional cell carcinoma: results of a Phase II prospective multicenter study.

Bartoletti R, Cai T, Gacci M, Giubilei G, Viggiani F, Santelli G, Repetti F, Nerozzi S, Ghezzi P, Sisani M; TUR (Toscana Urologia) Group. Bartoletti R, et al. Among authors: cai t. Urology. 2005 Oct;66(4):726-31. doi: 10.1016/j.urology.2005.04.062. Urology. 2005. PMID: 16230125 Clinical Trial.

7

Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.

Cai T, Margallo E, Nesi G, Giubilei G, Rizzo M, Bartoletti R. Cai T, et al. Oncol Rep. 2006 Jan;15(1):213-9. Oncol Rep. 2006. PMID: 16328058

8

Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study.

Gacci M, Bartoletti R, Cai T, Nerozzi S, Pinzi N, Repetti F, Viggiani F, Ghezzi P, Nesi G, Carini M; TUR (Toscana Urologia) Group. Gacci M, et al. Among authors: cai t. Urol Int. 2006;76(2):106-11. doi: 10.1159/000090870. Urol Int. 2006. PMID: 16493208 Clinical Trial.

9

Multiplex polymerase chain reaction for microsatellite analysis of urine sediment cells: a rapid and inexpensive method for diagnosing and monitoring superficial transitional bladder cell carcinoma.

Bartoletti R, Cai T, Dal Canto M, Boddi V, Nesi G, Piazzini M. Bartoletti R, et al. Among authors: cai t. J Urol. 2006 Jun;175(6):2032-7; discussion 2037. doi: 10.1016/S0022-5347(06)00283-7. J Urol. 2006. PMID: 16697794

10

Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.

Cai T, Nesi G, Boddi V, Mazzoli S, Dal Canto M, Bartoletti R. Cai T, et al. Oncol Rep. 2006 Aug;16(2):329-34. Oncol Rep. 2006. PMID: 16820911

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,887 results

Search Page

Filters